Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $5.8100 (-2.84%) ($5.8100 - $5.8100) on Thu. Sep. 7, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.3% (three month average) | RSI | 34 | Latest Price | $5.8100(-2.84%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA declines -1% a day on average for past five trading days. | Weekly Trend | IOVA declines -2.1% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) GDX(51%) SLV(49%) IPO(48%) GDXJ(47%) INDA(35%) | Factors Impacting IOVA price | IOVA will decline at least -2.15% in a week (0% probabilities). TAN(-53%) UUP(-47%) XRT(-35%) XME(-34%) TBT(-33%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.15% (StdDev 4.3%) | Hourly BBV | -1.1 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-8.6(-248.02%) | Resistance Level | $6.36 | 5 Day Moving Average | $6(-3.17%) | 10 Day Moving Average | $6.05(-3.97%) | 20 Day Moving Average | $6.36(-8.65%) | To recent high | -34.3% | To recent low | 0% | Market Cap | $851m | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |